Other Income & Expense
Equity Method Investment Impairment
Medtronic Equity Method Investment Impairment decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2024
Last reportedQ3 2026Feb 24, 2026
How to read this metric
An increase signals poor performance or strategic failure of a partner company.
Detailed definition
Represents a non-cash charge taken when the carrying value of an equity method investment exceeds its fair value due to...
Peer comparison
Rare but significant; peer companies report this when specific joint ventures or minority stakes underperform.
Metric ID:
ms_equity_method_investment_impairmentHistorical Data
3 periods
| Q3 '24 | Q3 '25 | Q3 '26 | |
|---|---|---|---|
| Value | $0.00 | $71.00M | $0.00 |
| QoQ Change | — | — | -100.0% |
| YoY Change | — | — | -100.0% |
Range$0.00 – $71.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Equity Method Investment Impairment at Other Companies
Frequently Asked Questions
- What is Medtronic's equity method investment impairment?
- Medtronic (MDT) reported equity method investment impairment of $0.00 in Q4 2025.
- What does equity method investment impairment mean?
- A write-down in the value of a business the company partially owns.